3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
17
Lymphoma, Non-Hodgkin
12
Hodgkin Disease
12
Multiple Myeloma
11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Leukemia, Lymphocytic, Chronic, B-Cell
9
Myeloproliferative Disorders
8
Recurrence
7
Melanoma
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia, Biphenotypic, Acute
7
Lymphoma
6
Leukemia
6
Anemia, Refractory, with Excess of Blasts
6
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Waldenstrom Macroglobulinemia
4
Neuroblastoma
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myelomonocytic, Juvenile
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Burkitt Lymphoma
4
Uveal Melanoma
3
Stomach Neoplasms
3
Primary Myelofibrosis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Interventions
Gemcitabine
29
pembrolizumab
21
Cisplatin
20
Specimen Handling
17
Magnetic Resonance Spectroscopy
17
enfortumab vedotin
10
Mitomycin
10
durvalumab
9
Cystoscopy
9
avelumab
8
Nivolumab
8
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
6
atezolizumab
5
Transurethral Resection of Bladder
5
Radiotherapy
5
Mitozytrex
5
Docetaxel
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Platinum
4
Immunoglobulin G
4
Disulfides
4
1,2-diaminocyclohexaneplatinum II citrate
4
disitamab vedotin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
fludarabine phosphate
×
90 days
×
Clear all
No trials found.